170 related articles for article (PubMed ID: 21696692)
21. Kaposi sarcoma: no longer an AIDS-defining illness? A retrospective study of Kaposi sarcoma cases with CD4 counts above 300/mm³ at presentation.
Daly ML; Fogo A; McDonald C; Morris-Jones R
Clin Exp Dermatol; 2014 Jan; 39(1):7-12. PubMed ID: 23691969
[TBL] [Abstract][Full Text] [Related]
22. Unknown: Unusual exophytic nodule on the plantar foot.
Chambers C; Sharon V; Fazel N
Dermatol Online J; 2010 Apr; 16(4):11. PubMed ID: 20409418
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.
Borok M; Fiorillo S; Gudza I; Putnam B; Ndemera B; White IE; Gwanzura L; Schooley RT; Campbell TB
Clin Infect Dis; 2010 Aug; 51(3):342-9. PubMed ID: 20572760
[TBL] [Abstract][Full Text] [Related]
24. [Kaposi's sarcoma localized on the shaft of the penis].
Merimsky E; Ilie B; Kaver I; Braf Z
J Urol (Paris); 1987; 93(2):95-7. PubMed ID: 3585046
[TBL] [Abstract][Full Text] [Related]
25. A retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm(3).
Mani D; Neil N; Israel R; Aboulafia DM
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(5):279-85. PubMed ID: 19721098
[TBL] [Abstract][Full Text] [Related]
26. [AIDS-associated sarcoma Kaposi: features of clinical manifestations, dynamics on a background of antiretroviral therapy].
Iurchenko AV; Martynchuk NA; Vikhtiuk NV
Lik Sprava; 2011; (7-8):81-5. PubMed ID: 22768744
[TBL] [Abstract][Full Text] [Related]
27. Interferon therapy for Kaposi sarcoma associated with acquired immunodeficiency syndrome: still a valid treatment option?
Rouanet I; Lechiche C; Doncesco R; Mauboussin JM; Sotto A
AIDS Patient Care STDS; 2013 Oct; 27(10):537-8. PubMed ID: 24050760
[No Abstract] [Full Text] [Related]
28. New drug targets in Kaposi sarcoma.
Sullivan RJ; Pantanowitz L
Expert Opin Ther Targets; 2010 Dec; 14(12):1355-66. PubMed ID: 21043836
[TBL] [Abstract][Full Text] [Related]
29. Pigmentary sequelae of AIDS-related cutaneous Kaposi sarcoma: successful treatment by Q-switched 755-nm alexandrite and 532-nm Nd:YAG lasers.
Hughes R; Lacour JP; Passeron T
Arch Dermatol; 2011 Jul; 147(7):779-81. PubMed ID: 21768476
[No Abstract] [Full Text] [Related]
30. Oral HIV-associated Kaposi sarcoma.
Pantanowitz L; Khammissa RA; Lemmer J; Feller L
J Oral Pathol Med; 2013 Mar; 42(3):201-7. PubMed ID: 22672182
[TBL] [Abstract][Full Text] [Related]
31. Complete regression of AIDS-related Kaposi's sarcoma-associated human herpesvirus-8 during therapy with indinavir.
Martinelli C; Zazzi M; Ambu S; Bartolozzi D; Corsi P; Leoncini F
AIDS; 1998 Sep; 12(13):1717-9. PubMed ID: 9764794
[No Abstract] [Full Text] [Related]
32. Treatment of Kaposi sarcoma in human immunodeficiency virus-1-infected Mozambican children with antiretroviral drugs and chemotherapy.
Vaz P; Macassa E; Jani I; Thome B; Mahagaja E; Madede T; Muando V; Biberfeld G; Anderson S; Blanche S
Pediatr Infect Dis J; 2011 Oct; 30(10):891-3. PubMed ID: 21730886
[TBL] [Abstract][Full Text] [Related]
33. Resolution of conjunctival Kaposi sarcoma after institution of highly active antiretroviral therapy alone.
Leder HA; Galor A; Peters GB; Kedhar SR; Dunn JP; Thorne JE
Br J Ophthalmol; 2008 Jan; 92(1):151. PubMed ID: 18156387
[No Abstract] [Full Text] [Related]
34. Peginterferon alfa-2a for AIDS-associated Kaposi sarcoma: experience with 10 patients.
Rokx C; van der Ende ME; Verbon A; Rijnders BJ
Clin Infect Dis; 2013 Nov; 57(10):1497-9. PubMed ID: 23912848
[TBL] [Abstract][Full Text] [Related]
35. Improvement of symptomatic human immunodeficiency virus-related lymphoid interstitial pneumonia in patients receiving highly active antiretroviral therapy.
Dufour V; Wislez M; Bergot E; Mayaud C; Cadranel J
Clin Infect Dis; 2003 May; 36(10):e127-30. PubMed ID: 12746792
[TBL] [Abstract][Full Text] [Related]
36. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
37. Clinical activity of lenalidomide in visceral human immunodeficiency virus-related Kaposi sarcoma.
Steff M; Joly V; Di Lucca J; Feldman J; Burg S; Sarda-Mantel L; Peytavin G; Marinho E; Crickx B; Raymond E; Lariven S; Maubec E
JAMA Dermatol; 2013 Nov; 149(11):1319-22. PubMed ID: 24080749
[TBL] [Abstract][Full Text] [Related]
38. [Disseminated histoplasmosis in a HIV seropositive patient with Kaposi sarcoma].
Garavelli PL; Rosa F; Brustia D; Brondolo R; Borrè S; Rizzo G
Recenti Prog Med; 2005 Oct; 96(10):492. PubMed ID: 16491772
[TBL] [Abstract][Full Text] [Related]
39. Acquired immune deficiency syndrome-related epidemic Kaposi sarcoma.
Steuer AB; Cohen JM; Christman MP; Penn LA; Brinster N; Femia AN
Dermatol Online J; 2018 Dec; 24(12):. PubMed ID: 30677797
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8.
Cassol E; Page T; Mosam A; Friedland G; Jack C; Lalloo U; Kopetka J; Patterson B; Esterhuizen T; Coovadia HM
J Infect Dis; 2005 Feb; 191(3):324-32. PubMed ID: 15633090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
